Changing the UK COVID-19 vaccine dosing schedule - POST
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study | Reuters
How to choose a COVID-19 vaccine booster shot
AstraZeneca boss Soriot says do not rush needlessly into COVID booster vaccines -The Telegraph | Reuters
Explainer: The confusion of Covishield dosing | Mint
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
COVID-19 Vaccine: Booster Dose
COVID-19 vaccine breakthrough infections | Science
AstraZeneca vaccine booster works against Omicron, Oxford lab study finds | Zee Business
AstraZeneca's vaccine hopes lie overseas as it runs out of road in UK
Chart: Pfizer Losing Efficacy Faster Against Delta Variant | Statista
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses | Nature Medicine
First U.S. 'Mix and Match' COVID Booster Data Are In | MedPage Today
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
COVID-19 vaccination | healthdirect
PR Thai Government - The Center for COVID-19 Situation Administration (CCSA) has approved shortening the period of the third dose, or booster dose, to tackle the COVID-19 Omicron variant, which is spreading
Booster Interval Now Three Months For AstraZeneca, Pfizer Recipients - CodeBlue
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Ontario to allow COVID-19 vaccine booster shots to seniors 70+, AstraZeneca recipients among others | Globalnews.ca
